What is the current Price Target for the vTv Therapeutics, Inc. Class A stock?

The average vTv Therapeutics, Inc. Class A target price is $36.21. This is 42.17% higher than the current stock price. The highest price target is 48.41%, the lowest is 38.79%. 4 Analysts have issued a price target vTv Therapeutics, Inc. Class A 2026 .

How high will the vTv Therapeutics, Inc. Class A stock rise?

No reliable answer can be given as to how high the vTv Therapeutics, Inc. Class A stock will rise. The performance of stocks, including the vTv Therapeutics, Inc. Class A stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the vTv Therapeutics, Inc. Class A stock today?

The performance of vTv Therapeutics, Inc. Class A stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the vTv Therapeutics, Inc. Class A stock fall?

The decline in vTv Therapeutics, Inc. Class A stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

vTv Therapeutics, Inc. Class A Forecast, price target & analysts

$25.47

5.07% yesterday

Nasdaq, Nov 06, 10:00 pm CET

ISIN

US9183851057

Symbol

VTVT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

vTv Therapeutics, Inc. Class A Target price 2025 - Analyst rating & recommendation

vTv Therapeutics, Inc. Class A Classifications & Recommendation:

Buy

88%

Hold

13%

vTv Therapeutics, Inc. Class A Price Target

Target Price	$36.21
Price	$25.47
Potential	42.17% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target vTv Therapeutics, Inc. Class A 2026 . The average vTv Therapeutics, Inc. Class A target price is $36.21. This is 42.17% register free of charge higher than the current stock price. The highest price target is $37.80 48.41% register free of charge , the lowest is $35.35 38.79% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend vTv Therapeutics, Inc. Class A to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the vTv Therapeutics, Inc. Class A stock has an average upside potential 2026 of 42.17% register free of charge . Most analysts recommend the vTv Therapeutics, Inc. Class A stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.20	-3.72
	67.04%	16.25%
P/E		negative

4 Analysts have issued a vTv Therapeutics, Inc. Class A forecast for earnings per share. The average vTv Therapeutics, Inc. Class A EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.20	67.04%
2025	$-3.72 16.25% Unlock
2026	$-3.82 2.69% Unlock
2027	$-4.23 10.73% Unlock
2028	$-3.52 16.78% Unlock
2029	$-2.71 23.01% Unlock
2030	$-2.24 17.34% Unlock

Current	-8.60	105.46%
2025	-6.85 20.39% Unlock
2026	-6.67 2.63% Unlock
2027	-6.02 9.75% Unlock
2028	-7.24 20.27% Unlock
2029	-9.39 29.70% Unlock
2030	-11.35 20.87% Unlock

vTv Therapeutics, Inc. Class A...

Current vTv Therapeutics, Inc. Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 13 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 09 2025
Alliance Global Partners	Locked ➜ Locked	Locked	Dec 09 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 13 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 09 2025
Locked Alliance Global Partners: Locked ➜ Locked	Dec 09 2024

Discover more stocks with a high price target

TUI 61.53%

Novo Nordisk 52.03%

Adidas 51.38%

Deutsche Telekom 47.10%

Meta Platforms (Facebook) 44.20%

Coinbase Global, Inc. 39.58%

BYD 39.24%

Adyen 36.70%

BioNTech SE - ADR 34.72%

Rheinmetall 31.38%

Microsoft 29.27%

Netflix 29.24%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now